FdaApplication

NDA 208462

Back to search

Identifiers

Properties

PropertyValue
applicant_nameTAKEDA PHARMACEUTICALS USA INC
application_typeNDA
approval_date2015-11-20

Products (3)

ProductActive ingredientStrengthDosage form
NINLAROIXAZOMIB CITRATEEQ 2.3MG BASECAPSULE;ORAL
NINLAROIXAZOMIB CITRATEEQ 4MG BASECAPSULE;ORAL
NINLAROIXAZOMIB CITRATEEQ 3MG BASECAPSULE;ORAL

3 products